we have recently generated transgenic mice with cardiacspecific overexpression of DGK (DGK -TG) using an -myosin heavy chain (MHC) promoter and demonstrated that DGK negatively regulated the hypertrophic signaling cascade and resultant cardiac hypertrophy in response to GPCR agonists without detectable adverse effects. 17 These results suggest that DGK may play a pivotal role in regulating the G q signaling cascade.
In the present study, we generated double transgenic mice (G q/DGK -TG) with cardiac-specific overexpression of both DGK and G q by crossing G q-TG mice with DGK -TG mice and tested the hypothesis that DGK could rescue the G q-TG mice from developing HF.
Methods

Animals
DGK -TG mice were created in our institution as previously reported 17 and G q-TG mice were kindly provided by Dr Mende. 7 Mice were housed in a facility with a 12/12-h light/dark cycle and were given free access to water and standard rodent chow. The room was kept specific-pathogenfree. All experimental procedures were performed according to the animal welfare regulations of Yamagata University School of Medicine, and the study protocol was approved by the Animal Subjects Committee of Yamagata University School of Medicine. The investigation conformed to the Guide for the Care and Use of Laboratory Animals published by the US National Institutes of Health.
Crossing of different mouse strains (DGK -TG:BDF-1, G q-TG:FVB/N) may produce unwanted experimental variables and potentially modify the transgenic phenotype. Thus, G q-TG mice were backcrossed for 6 generations with BDF-1 mice before the mating of DGK -TG mice with G q-TG mice was initiated. The genotypes of the wild-type (WT), DGK -TG, G q-TG, and G q/DGK -TG mice were identified by polymerase chain reaction (PCR) with the use of tail genomic DNA, as previously reported. 7, 17 
Echocardiography and Cardiac Catheterization
Transthoracic echocardiography of the 16-week-old mice was recorded as described previously with an FFsonic 8900 (Fukuda Denshi Co, Tokyo, Japan) equipped with a 13-MHz phased-array transducer. [18] [19] [20] Left ventricular (LV) internal dimensions at end-systole and end-diastole (LVESD and LVEDD) and LV posterior wall thickness were measured digitally on the M-mode tracings and averaged from at least 3 cardiac cycles. [18] [19] [20] LV fractional shortening (LVFS) was calculated as [(LVEDD -LVESD)/LVEDD]×100.
Cardiac catheter examination by a closed-chest approach was performed as described previously. 21 The right carotid artery was cannulated under anesthesia by a micro-pressure transducer with an outer diameter of 0.42 mm (Samba 3200; Samba Sensors AB), which was then advanced into the left ventricle. Heart rate, LV end-diastolic pressure (LVEDP), end-systolic pressure, maximal and minimum rates of LV pressure development (+dP/dt and -dP/dt, respectively) were measured using an Acqknowledge ® version 3.8.1 system with a sampling rate of 2,000 Hz. The time constant of LV isovolumic relaxation, Tau, was calculated by a modification of the method described by Weiss et al, 22 in which Tau is equal to -1/slope of the regression line for the natural logarithm of LV pressure vs time for the period from peak -dP/dt to 5 mmHg above LVEDP.
Morphological and Histopathological Examinations
At 16 weeks old, mice were killed, their coronary arteries were retrogradely flushed with saline, and the heart, lungs, and liver were excised and weighed. The heart was fixed with a 10% solution of formalin in phosphate-buffered saline at 4°C for 24 h, embedded in paraffin, and then cut serially from the apex to the base. 19, 20 Three sections were stained with hematoxylin/eosin or Masson's trichrome stain for histopathological analysis. Transverse sections were captured digitally, and cardiomyocyte cross-sectional area was measured using a Scion imaging system (Scion Corporation, Frederick, MD, USA). 20, 23 We traced the outline of at least 200 cardiomyocytes in each section, and the data were averaged.
To assess the degree of fibrosis the sections stained with Masson's trichrome stain were scanned with computerassisted video densitometry, and the images from at least 10 fields for each heart were analyzed, as described previously. 17, 20 The fibrosis fraction was obtained by calculating the ratio of van Masson's trichrome-stained connective tissue area (stained blue) to total myocardial area (stained red) with image analysis software as described previously. 20, 23 
PKC Isoforms Translocation
Membranous and cytosolic fractions of detergent-extracted PKC were prepared from the LV myocardium as described previously. 6, 10, 24 Protein concentration of myocardial samples was carefully determined by protein assay, and equal amounts of protein extracts from the membranous and cytosolic fractions were loaded onto each gel lane. Equal amounts of membranous and cytosolic protein were subjected to 10% SDS-PAGE electrophoresis and transferred to PVDF membranes. To ensure equivalent protein loading and quantitative transfer efficiency of proteins, membranes were stained with Ponceau S. before incubating with primary antibodies. Subcellular localization of the PKC isoforms was examined by quantitative immunoblotting using isoformspecific antibodies (mouse monoclonal anti-PKC , , , and , Santa Cruz Biotechnology, Inc, Santa Cruz, CA, USA) as reported previously. 6, 10, 24 Immunoreactive bands were detected by an ECL kit (Amersham Biosciences Corp, Piscataway, NJ, USA), and membrane/cytosol (M/C) ratios of immunoreactivity were used as indices for the extent of translocation of PKC isoforms. 6, 10, 24 
Phosphorylation Activity of Mitogen-Activated Protein Kinase (MAPK) Family
The total protein from the LV myocardium was extracted as reported previously. 24, 25 To examine phosphorylation activity of ERK, c-jun N-terminal kinase (JNK) and p38 MAPK, Western blotting was performed with anti-phosphospecific ERK, JNK and p38 MAPK antibodies (Promega Corporation, Madison, WI, USA) as reported previously. 26 To quantify the protein levels, the same membranes were re-probed with nonspecific anti-ERK, JNK and P38 MAPK antibodies (Santa Cruz Biotechnology). 26 The relative amount of phosphorylated proteins to total proteins was used for phosphorylation activity.
Extraction of RNA and Real-Time Reverse Transcriptase (RT) -PCR
Total RNAs were extracted from the LV myocardium using TRIzol (Invitrogen, Tokyo, Japan) and first-strand cDNA was synthesized from 1 g of RNA sample with oligo (dT) primers and superscript II reverse transcriptase as previ-ously described. 16, 17, 20 To examine mRNA expression levels of atrial natriuretic factor (ANF), -MHC, B-type natriuretic peptide (BNP), -skeletal actin, collagen type I, and collagen type III, real-time PCR amplification was performed as reported previously. 16, 17, 20 Reagents were purchased from Roche Diagnostics Japan (Tokyo, Japan). Amplification was performed using a LightCycler DNA Master SYBR Green I in a 20-l volume reaction and analyzed using LightCycler Software Ver.3.5 (Roche Diagnostics Japan). Standard curves of these genes were generated by full-sequence plasmid of known concentrations. Gene expressions were normalized to glyceraldehyde 3-phosphate dehydrogenase (GAPDH). Primers were designed based on GenBank sequences (ANF, K02781; -MHC, AY056464; BNP, NM 008726; -skeletal actin, NM009606; collagen type I, NM 007742; collagen type III, NM009930; and GAPDH, NM 001001303).
Statistical Analysis
All values are reported as the mean ± SD. Gravimetric data, histological data, PKC translocation, MAPK phosphorylation activity, echocardiographic data, cardiac catheterization data, and RT-PCR data were analyzed by 1-way ANOVA or the Kruskal-Wallis test followed by multiple comparisons with the Fisher's protected least significant difference test. Survival curves were created by the KaplanMeier method and compared by log-rank test. A value of p<0.05 was considered statistically significant.
Results
Expression of DGK Prevents G q-TG Mice From Developing Cardiomegaly
To evaluate whether expression of DGK could rescue G q-TG mice from developing HF, cardiac morphology was examined in WT, DGK -TG, G q-TG, and G q/DGK -TG mice. As shown in Fig 1, 16 -week-old G q-TG mice presented marked cardiomegaly. Their hearts had massive biventricular and bi-atrial dilation with frequent atrial mural thrombi, indicative of a low cardiac output state. DGK -TG mice showed no morphological abnormality, as previously reported. 17 Expression of DGK in the G q-TG mouse heart was able to prevent cardiomegaly in G q-TG mice (Fig 1) . The heart/body weight ratio decreased in G q/DGK -TG mice compared with G q-TG mice (5.89±0.91 vs 7.43±1.68, p<0.01) as shown in Table 1 .
DGK Rescues Contractile Dysfunction and Overt HF in G q-TG Mice
Echocardiography was performed in 16-week-old mice, and representative M-mode echocardiograms are shown in Fig 2. As shown in Fig 2 and creased LVEDD were significantly improved compared to G q-TG mice as shown in Fig 2 and Table 2 .
Cardiac catheterization was performed in the 16-weekold mice. Under anesthesia, the systolic and diastolic blood pressures were similar among WT, DGK -TG, G q-TG, and G q/DGK -TG mice, but the heart rate was significantly lower in G q-TG mice compared with the WT, DGK -TG, and G q/DGK -TG mice ( Table 2 ). As shown in Table 2 , G q-TG mice exhibited cardiac dysfunction and HF, as demonstrated by increased LVEDP, reduced +dP/dt, -dP/dt and prolonged Tau compared with the WT and DGK -TG mice. However in the G q/DGK -TG mice, LVEDP elevation and Tau prolongation were significantly attenuated compared with G q-TG mice. Although statistically not significant, there was a tendency of improved +dP/dt and -dP/dt in G q/DGK -TG mice compared with G q-TG mice.
Translocation of PKC Isoforms and Phosphorylation Activity of MAPK
We examined the expression and subcellular translocation of the PKC isoforms in WT, DGK -TG, G q-TG, and G q/DGK -TG mice at 16 weeks old. As shown in Fig 3, we detected increased expression and translocation of the PKC , , , and isoforms in G q-TG mice. However in the G q/DGK -TG mice, translocation of PKC and PKC , but not and , were significantly attenuated compared with G q-TG mice (Fig 3) (p=0.0101 and p=0 .0127 vs G q-TG mice, respectively).
Next we examined the phosphorylation activities of ERK, JNK and p38 MAPK in WT, DGK -TG, G q-TG, and G q/DGK -TG mice at 16 weeks old. As shown in Fig 4, we detected activation of JNK and p38 MAPK in G q-TG mice; however, in the G q/DGK -TG mice, the phosphorylation activities of JNK and p38 MAPK were significantly attenuated compared with G q-TG mice (Fig 4) (p=0.0480 and p=0.0411 vs G q-TG mice, respectively). We could not detect activation of ERK in G q-TG mouse hearts at 16 weeks old.
DGK Prevents Fetal Gene Induction and Cardiomyocyte Hypertrophy in G q-TG Mice
We next examined the mRNA expressions of fetal type genes such as ANF, -MHC, BNP, and -skeletal actin in WT, DGK -TG, G q-TG, and G q/DGK -TG mice at 16 weeks old. Expressions of ANF, -MHC, BNP, and -skeletal actin were significantly upregulated in G q-TG mice compared with WT and DGK -TG mice (Fig 5) . Conversely in G q/DGK -TG mouse hearts, gene induction of ANF, -MHC, and BNP, but not -skeletal actin, was significant- ly attenuated compared with G q-TG mice (Fig 5) . Microscopic observation revealed no significant difference between WT and DGK -TG mice in cardiomyocyte cross-sectional area, as previously reported. 17 Cardiomyocyte cross-sectional area was profoundly increased in G q-TG mice at 16 weeks old compared with WT and DGK -TG mice (p<0.0001) (Fig 6) . However, the increase in cardiomyocyte cross-sectional area was significantly attenuated in G q/DGK -TG mice compared with G q-TG mice (286±25 m 2 vs 461±43 m 2 , p<0.0001).
Myocardial Fibrosis and Expression of Profibrotic Genes
Because reactive interstitial and perivascular fibrosis adversely alters myocardial stiffness and ultimately leads to LV dysfunction, 18 we examined myocardial fibrosis at 16 weeks in WT, DGK -TG, G q-TG, and G q/DGK -TG mice using sections stained with Masson's trichrome stain (Fig 7A) . Prominent perivascular and interstitial fibrosis was observed in G q-TG mice, as reported in a previous study. 7 However, the degree of myocardial fibrosis was much less in G q/DGK -TG mice than in G q-TG mice (Fig 7) (fibrosis fraction: 1.6±1.7% vs 11.1±3.4%, p<0.0001).
We next examined the expression of profibrotic genes, such as collagen type I and collagen type III, to investigate whether these morphological observations were accompanied by alterations in gene expressions relevant to fibrotic changes (Fig 7B) . RT-PCR revealed that collagen type I and collagen type III mRNA at 16 weeks were markedly upregulated in G q-TG mice, compared with WT and DGK -TG mice, and these responses were significantly attenuated in G q/DGK -TG mice compared with G q-TG mice (Fig 7B) .
DGK Improves Survival of G q-TG Mice
As shown in Fig 8, the Kaplan-Meier survival analysis showed that cumulative survival probability for G q-TG mice was significantly shorter compared with WT and DGK -TG mice. Most deaths were from HF, which was preceded by the development of pleural effusion, ascites and edema. Over a 1-year follow-up period, the probability of survival was approximately 23% for the G q-TG mice compared with 98% for WT mice and 97% for DGK -TG mice. However, over the same period, G q/DGK -TG mice showed a probability of survival of 75% (p<0.0001 vs G q-TG mice by log-rank test). These data clearly demonstrated that cardiac-specific expression of DGK improved the survival of G q-TG mice.
Discussion
In the present study, we have reported the first evidence that expression of DGK in the hearts of G q-TG mice in- hibits cardiac chamber dilatation and improves the cardiac systolic function and survival of G q-TG mice. We have also shown that cardiac hypertrophy, fibrosis, induction of fetal and profibrotic genes, translocation of PKC isoforms, and phosphorylation activity of MAP kinases in G q-TG mice were significantly blocked in G q/DGK -TG mice. Attenuation of the GPCR signaling pathway through cardiac-specific DGK expression protected G q-TG mice from developing lethal HF, suggesting that DGK represents a novel therapeutic target for HF.
HF remains the leading cause of mortality, and intense investigation has focused on defining the signaling pathways responsible for the development of cardiac hypertrophy and HF. 3 In particular, numerous investigations have demonstrated the importance of the G q-mediated signaling in the development of cardiac hypertrophy and HF. 7, 8, 27 We previously showed that DGK inhibits GPCR agonist-induced hypertrophic signaling and resultant cardiac hypertrophy in vitro and in vivo, 16, 17 and recently we also showed that DGK attenuates LV remodeling and improves survival after myocardial infarction. 28 DGK suppresses the cardiac hypertrophy and fibrosis caused by pressure overload. 29 In this study, phosphorylation activity of JNK and p38 MAPK in G q-TG mice was significantly attenuated (Fig 4) , but the G q-TG mice showed activation of JNK and p38 MAPK in vivo, as in previous reports. 21, 30 It has been reported that G q stimulation by the GPCR agonist activates JNK and p38 MAPK through phospholipase C and PKC pathways in the cardiomyocyte, and that these pathways act as potent signals for cardiac hypertrophy and progression to HF. 31 Furthermore, in previous studies activation of JNK via PKC ( and isoforms) played an important role in cell proliferation and differentiation, and a PKC inhibitor significantly suppressed phosphorylation activity of JNK. [32] [33] [34] Therefore, inhibition of PKC translocation by DGK might contribute to the blockade of JNK and p38 MAPK activation observed in the present study. Although this signal pathway has not been fully elucidated, inhibition of this pathway by DGK might be a novel therapeutic target for HF.
Matthew et al reported that DGK , but not other DGK isoforms, completely inhibited Ras activation induced by RasGRP, which has a DAG-binding domain and is activated by DAG. 35 Ras, which is a small G protein, plays an important role in the activation of JNK and p38 MAPK, leading to HF as previously reported. 36, 37 Attenuation of the Ras signaling cascade by DGK is one of the possible mechanisms for rescue of G q-TG mice from developing lethal HF, as observed in the present study.
It has been reported that cardiac fibrosis leads to reduced myocardial elasticity and contractility, which ultimately lead to congestive HF. 38, 39 In our present study, histological examination demonstrated that fibrosis by G q was suppressed in G q/DGK -TG mice (Fig 7A) . Furthermore, gene expressions of collagen type I and collagen type III were significantly attenuated in G q/DGK -TG mice compared with G q-TG mice (Fig 7B) . The reduced fibrosis fraction might relate to the improvement in Tau, an index of diastolic function, in G q/DGK -TG mice observed in the present study.
Previous studies report that the combination of G q and the PKC activator peptide in double transgenic mice stimulates reactive fibrosis, impairing both systolic and diastolic function, and leading to early HF and premature lethality. In contrast, the combination of G q and the PKC inhibitor peptide in double transgenic mice improved systolic and diastolic function. 40, 41 In the present study, PKC activity was increased in G q-TG mice, as previously reported, 8 but translocation of PKC was significantly attenuated in G q/ DGK -TG mice. These data are consistent with our previous studies reporting that inhibition of PKC translocation by DGK attenuated fibrosis in the noninfarct area after myocardial infarction 28 and that caused by pressure overload. 29 Inhibition of PKC translocation by DGK might also have attenuated fibrosis in the G q-TG mice in this study.
DGK also blocked translocation of PKC in the G q/ DGK -TG mice compared with G q-TG mice in this study. A previous study has reported that the PKC isoform plays an important role in cardiac hypertrophy. 11 Our previous in vitro study using cultured rat neonatal cardiomyocytes has shown that DGK blocks endothelin-1-induced increases in protein synthesis concomitant with increases in cell size and reactivation of fetal genes via the inhibition of PKC . 16 In addition, DGK inhibits translocation of PKC and upregulation of ANF after GPCR agonists, such as angiotensin II and phenylephrine infusion, in mice. 17 These data are consistent with the present study's result that the inhibition of PKC by DGK might contribute to suppression of gene induction of ANF, -MHC, and BNP (Fig 5) and attenuation of increases in cross-sectional cardiomyocyte surface area (Fig 6) .
DAG and inositol 1, 4, 5-triphosphate are produced by activated phospholipase C-mediated hydrolysis of phosphatidylinositol 4, 5-bisphosphate. The inositol 1, 4, 5-triphosphate-calcineurin pathway plays an important role in stimulating the nuclear factor of activated T cells, which binds to DNA cooperatively with other hypertrophic transcription factors. 42 DAG is catalyzed by DGK to form phosphatidic acid, which itself has a signaling function, stimulates DNA synthesis, and modulates activity of several enzymes, including phosphatidylinositol 5-kinases, ERK, and others. 43 Therefore, it seems that DGK could not completely inhibit HF in G q-TG mice because of the influence of these pathways.
Conclusions
We have demonstrated that cardiac-specific expression of DGK blocked cardiac dysfunction and lethal HF in G q-TG mice without detectable adverse effects. These results give us a novel approach to investigating the pathogenesis of cardiac hypertrophy and decompensation leading to HF, and DGK may be a potential novel therapeutic target to prevent congestive HF.
